Status: Recruiting
Comparing Magnesium 2g Versus 4g Versus Placebo in the Incidence of Treating AFF RVR
The purpose of this prospective, randomized, double-blinded study is to further evaluate the safety and efficacy of varying doses of intravenous magnesium in the treatment of AFF RVR.
Participants needed: 153
Trial details
Phase: Phase 3Age: 18+Biological sex: AllType: InterventionalSponsor: Wake Forest University Health SciencesUpdated: Oct 28, 2025Locations: 1
Eligibility criteria
Age > 18 years or older [+4]
Hemodynamically unstable patients (SBP <90, MAP <65) [+11]